From: Rising trends towards the development of oral herbal male contraceptive: an insight review
Summary of invention | Patent number | Inventor/assignee |
---|---|---|
Substituted acylanilides and methods of use thereof | AU2015264895B2 | Dalton, James, Miller, Duane D. |
Styrene maleic anhydride based formulation for male contraception and prostate cancer | EP 2 268 290 B1 | Guha, Sujoy Kumar |
Lonidamine analogs and their use in male contraception and cancer treatment | EP 2 502 624 A1 | Chakrasali, Georg, Jakkaraj, Tash |
Orally active 7-alpha-alkyl androgens | EP1212345B1 | Louw Van Der, Leysen, Buma Bursi |
Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use | EP1272196B1 | Blye, Kim |
Oral pharmaceutical composition comprising 15-hydroxytestosterone and its analogues | EP1551415B1 | Bunschoten, Coelingh Bennink, Van Der Linden |
Male contraceptive formulation comprising norethisterone | US20020103176A1 | Eberhard Nieschlag, Axel Kamischke, Michael Oettel, Alexander Ruebig, Ekkerhard Schillinger, Habenicht Ursula-Friederike |
Male contraceptive method and composition | US20020164368A1 | Ronald Zimmerman |
Androgen as a male contraceptive and non-contraceptive androgen replacement | US20020193359A1 | Alfred J. Moo-Young |
Reversible infertility in male mice following oral administration of alkylated imino sugars: a non-hormonal approach to male contraception | US20040019082A1 | Aarnoud C. Van Der Spoel, Mylvaganam Jeyakumar, Terry D. Butters, Raymond A. Dwek, Frances M. Platt |
Non-hormonal compositions and methods for male contraception | US20190290615A1 | Guillaume Ei Glaoui, Mehdi Ei Glaoui, Philippe Perrin, Stéphane Droupy, Véronique Agathon–Meriau |
Reversible male contraception | US4252798 | Donald J. Tindall |
Male contraceptive steroids and methods of use | US4297350 | John C. Babcock; J. Allan Campbell, Thomas J. Lobl, |
Oral male contraceptive | US4381298 | Patricia B. Coulson, Sheffield Dr. |
Male contraceptive implant | US5733565 | Alfred J. Moo-Young, Saleh I. Saleh |
Male contraceptives | US5854254 | Susan H. Benoff |
Buccal drug delivery system for use in male contraception | US6180682 | Virgil A. Place |
High-strength testosterone undecanoate compositions | US9480690 | Chandrashekar Giliyar, Basawaraj Chickmath, Nachiannan Chidambaram, Srinivansan Venkateshwaran |
Male contraceptive comprising a prolactin inhibitor and a sex steroid | WO1999066935A1 | Lincoln, Kirkton Cottages, WU |
A pulmonary drug delivery composition containing a progestogen and androgen for use in a contraceptive method in males | WO2003068315A1 | Coelingh Bennink, Van Der Linden |
Novel spermicidal and anti-infective contraceptive device | WO2007074478A1 | Jain Rajesh, Jindal Kour Chand |
Substituted (5,6)-dihydronaphraalenyl compounds as reversible male contraceptives | WO2008137081A1 | Wolgemuth Debra J., Reczek Peter R. |
Inhibitors of eppin/semenogelin binding as male contraceptives | WO2009042565A2 | O’rand Michael G., Widgren Esther Elaine, Richardson Richard, Temple Brenda |
Non-hormonal male contraceptive agents and methods using same | WO2016205539A1 | Yan Wei |
Piperidine-dione derivatives for use as contraceptives | WO2018211276A1 | Sieng Bora, Lundvall, Steffi, Claudia Alejandra |